Illumina Genomics Research

Illumina Research and Innovation

At Illumina, innovation and research align with a commitment to scientific access, data, and community. These values underpin our leadership in genomic research and clinical applications.

Our scientists help drive progress in how we aggregate, analyze, and interpret genomic data for meaningful insights. Illumina research fuels innovative ways to study, diagnose, and treat disease. Explore some of our latest efforts here.

Recent Discoveries by Illumina Scientists

Overcoming the Diffraction Limit with Super-Resolution Optics to Increase Sequencing Cluster Density

The super-resolution imaging technique structured illumination microscopy can be adapted to increase and optimize the packing density of sequencing clusters.

Genotyping of High Homology HBA1 and HBA2 from Illumina Whole-Genome Sequencing

α-thalassemia is caused by mutations in high homology HBA1 and HBA2 genes (~97%). We present here a new WGS-based DRAGEN HBA caller that can accurately detect deletional and non-deletional variants in the HBA locus.

The Challenge of Somatic Variant Detection Accuracy in Liquid Biopsy Addressed by the DRAGEN Platform with UMIs

Illumina scientists present a method using unique molecular identifiers (UMIs) and the power of the DRAGEN platform to reduce noise and errors to enable accurate somatic variant calling in ctDNA.

Find open-source software, access developer resources, or explore our entire informatics portfolio.

New to data analysis? Visit our NGS data analysis page.

 
Open-Source Bioinformatics Tools

Explore a broad range of free open-source software provided and maintained by Illumina.

Learn More

 
Developer Portal

Start with powerful Illumina software, then use the APIs to customize your workflow from sample to insight.

Visit Portal

Informatics Portfolio

Our comprehensive software tools offer rapid, accurate secondary analysis, flexible and secure data storage, scalable infrastructure, and more.

Learn More

Metagenomics, COVID-19, & Emerging Pathogens

Robert Schlaberg and Lauge Farnaes from IdByDNA discuss use of metagenomics to identify emerging pathogens.

Genomic Tumor Profiling and Precision Oncology

Dr. Rachel Sanborn of the Providence Cancer Institute explains how genomics technologies are empowering precision oncology.

Join the best and brightest in the biotech industry. Collaborate with industry leaders, contribute to cutting-edge research, and ignite your passion for innovation.

Whether you're interested in basic genomics research, bioinformatics, engineering, or clinical product development, join us and make a difference. View our career profile videos to learn more about what it’s like to work at Illumina, or search current job openings.

Featured Opening

Bioinformatics Scientist

Bioengineer Career Profile

Find out what Erin Fang works on, who she works with, and what motivated her to pursue bioengineering.

View Video

Bioinformatician Career Profile

Find out how Daniel Brami spends his average day, and where he sees bioinformatics going in five years.

View Video

Genomics News

How Comprehensive Genomic Profiling Is Helping Cancer Patients Today
How Comprehensive Genomic Profiling Is Helping Cancer Patients Today

At ESMO 2022 in Paris, oncologists discussed real-world cases and big-picture challenges

Read Article
Towards early prevention of lifestyle related diseases – a cohort study starting at the fetal stage
Towards early prevention of lifestyle related diseases – a cohort study starting at the fetal stage

Associate Professor Kenichi Sakurai of Chiba University <br>Professor Yoichiro Kamatani of The University of Tokyo

Read Interview
Illumina Grant Boosts Climate Action and Job Training
Illumina Grant Boosts Climate Action and Job Training

US nonprofit GRID Alternatives launches new projects to provide renewable energy

Read Article